경구용 비스포스포네이트 관련 악골괴사의 합병증로 발생한 상악동염; 증례보고

MAXILLARY SINUSITIS AS A COMPLICATION OF ORAL BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW: A CASE REPORT

  • 김영란 (경희대학교 치의학전문대학원 구강악안면외과) ;
  • 권용대 (경희대학교 치의학전문대학원 구강악안면외과) ;
  • 이백수 (경희대학교 치의학전문대학원 구강악안면외과) ;
  • 최병준 (경희대학교 치의학전문대학원 구강악안면외과) ;
  • ;
  • Kim, Yeong-Ran (Department of Oral & Maxillofacial Surgery, Kyung Hee University Dental School) ;
  • Kwon, Yong-Dae (Department of Oral & Maxillofacial Surgery, Kyung Hee University Dental School) ;
  • Lee, Baek-Soo (Department of Oral & Maxillofacial Surgery, Kyung Hee University Dental School) ;
  • Choi, Byung-Joon (Department of Oral & Maxillofacial Surgery, Kyung Hee University Dental School) ;
  • Walter, Christian (Department of Oral & Maxillofacial Surgery, Johannes-Gutenberg University Mainz) ;
  • Al-Nawas, Bilal (Department of Oral & Maxillofacial Surgery, Johannes-Gutenberg University Mainz)
  • 발행 : 2009.02.28

초록

Maxillary sinusitis is an infectious disease which can arise from odontogenic etiology and a maxillary osteomyelitis can spread into the sinus and consequently develop maxillary sinusitis. In this case report, a mid eighty's lady was diagnosed as BRONJ with maxillary sinusitis as a complication. The patient was managed successfully in collaboration with a endocrinologist. Through serial follow-up of serum CTX, we could decide the timing of surgical intervention.

키워드

참고문헌

  1. Khalid AN, Hunt J, Perloff JR, Kennedy DW: The role of bone in chronic rhinosinusitis. Laryngoscope 2002;112:1951 https://doi.org/10.1097/00005537-200211000-00008
  2. Marx RE: Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61:1115 https://doi.org/10.1016/S0278-2391(03)00720-1
  3. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL: Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527 https://doi.org/10.1016/j.joms.2004.02.004
  4. Kwon Y-D, Yoon B-W, Walter C: Bisphosphonate, is it an emerging risk factor in oral surgery? J Korean Assoc Maxillofac Plast Reconstr Surg 2007;29:456
  5. Walter C, Grotz KA, Kunkel M, Al-Nawas B: Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 2007;15:197 https://doi.org/10.1007/s00520-006-0120-z
  6. Koulocheris P, Weyer N, Liebehenschel N et al.: Suppurative maxillary sinusitis in patients with bisphosphonate-associated osteonecrosis of the maxilla: report of 2 cases. J Oral Maxillofac Surg 2008;66:539 https://doi.org/10.1016/j.joms.2007.05.014
  7. Legert KG, Zimmerman M, Stierna P: Sinusitis of odontogenic origin: pathophysiological implications of early treatment. Acta Otolaryngol 2004;124:655 https://doi.org/10.1080/00016480310016866
  8. Marx RE, Sawatari Y, Fortin M, Broumand V: Bisphosphonateinduced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567 https://doi.org/10.1016/j.joms.2005.07.010
  9. Rosen HN, Moses AC, Garber J et al.: Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 2000;66:100 https://doi.org/10.1007/PL00005830